MUFG Americas’s Harvard Bioscience HBIO Stock Holding History

MUFG Americas’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-355	Closed	-$20K	–	1190
2015 Q2	$20K	Hold	355	–	–	﹤0.01%	754
2015 Q1	$21K	Buy	355 +71	+25%	+$3.81K	﹤0.01%	800
2014 Q4	$16K	Buy	284 +107	+60%	+$5.1K	﹤0.01%	860
2014 Q3	$7K	Buy	+177	New	+$8.14K	﹤0.01%	1011

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MUFG Americas's HBIO Position: Q3 2015 in Review

MUFG Americas sold out of Harvard Bioscience (HBIO) in Q3 2015, closing a stake of 355 shares — an estimated $20K sold.

MUFG Americas first reported a position in HBIO in Q3 2014 and held it in 4 quarters. The position peaked at $21K in Q1 2015. 84 funds tracked by Wall St. Rank hold HBIO as of Q3 2015.

MUFG Americas reported no remaining Harvard Bioscience position as of Q3 2015 after selling out during the quarter.
MUFG Americas sold 355 Harvard Bioscience shares in Q3 2015, an estimated $20K.
MUFG Americas first reported a position in Harvard Bioscience in Q3 2014 and held it in 4 quarters.
MUFG Americas's Harvard Bioscience position peaked at $21K in Q1 2015.
84 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2015.

Based on MUFG Americas's 13F filing for Q3 2015, filed 10 Nov 2015.